Viewing Study NCT02248168


Ignite Creation Date: 2025-12-24 @ 5:36 PM
Ignite Modification Date: 2026-01-02 @ 9:41 AM
Study NCT ID: NCT02248168
Status: COMPLETED
Last Update Posted: 2014-09-25
First Post: 2014-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease
Sponsor: Boehringer Ingelheim
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 248.599
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators